589 related articles for article (PubMed ID: 26338824)
1. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.
He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z
Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824
[TBL] [Abstract][Full Text] [Related]
2. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
[TBL] [Abstract][Full Text] [Related]
3. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
4. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting T
Zhou G; Wu W; Yu L; Yu T; Yang W; Wang P; Zhang X; Cong Y; Liu Z
J Allergy Clin Immunol; 2018 Oct; 142(4):1218-1228.e12. PubMed ID: 29113905
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-425 facilitates pathogenic Th17 cell differentiation by targeting forkhead box O1 (Foxo1) and is associated with inflammatory bowel disease.
Yang X; He Q; Guo Z; Xiong F; Li Y; Pan Y; Gao C; Li L; He C
Biochem Biophys Res Commun; 2018 Feb; 496(2):352-358. PubMed ID: 29331376
[TBL] [Abstract][Full Text] [Related]
6. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
[TBL] [Abstract][Full Text] [Related]
7. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD.
Wu W; He C; Liu C; Cao AT; Xue X; Evans-Marin HL; Sun M; Fang L; Yao S; Pinchuk IV; Powell DW; Liu Z; Cong Y
Gut; 2015 Nov; 64(11):1755-64. PubMed ID: 25281418
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases.
Ge Y; Sun M; Wu W; Ma C; Zhang C; He C; Li J; Cong Y; Zhang D; Liu Z
J Autoimmun; 2019 Jul; 101():109-120. PubMed ID: 31014918
[TBL] [Abstract][Full Text] [Related]
9. Critical role of ROCK2 activity in facilitating mucosal CD4
Yang W; Zhou G; Yu T; Chen L; Yu L; Guo Y; Cong Y; Liu Z
J Autoimmun; 2018 May; 89():125-138. PubMed ID: 29269245
[TBL] [Abstract][Full Text] [Related]
10. miR-802 participates in the inflammatory process of inflammatory bowel disease by suppressing SOCS5.
Yao J; Gao R; Luo M; Li D; Guo L; Yu Z; Xiong F; Wei C; Wu B; Xu Z; Zhang D; Wang J; Wang L
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211804
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
[TBL] [Abstract][Full Text] [Related]
12. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
14. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
Nie J; Zhao Q
Front Immunol; 2020; 11():852. PubMed ID: 32547537
[No Abstract] [Full Text] [Related]
15. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease.
Shi Y; Dai S; Qiu C; Wang T; Zhou Y; Xue C; Yao J; Xu Y
Mucosal Immunol; 2020 Mar; 13(2):303-312. PubMed ID: 31628427
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease.
Igaki K; Nakamura Y; Tanaka M; Mizuno S; Yoshimatsu Y; Komoike Y; Uga K; Shibata A; Imaichi H; Takayuki S; Ishimura Y; Yamasaki M; Kanai T; Tsukimi Y; Tsuchimori N
Inflamm Res; 2019 Jun; 68(6):493-509. PubMed ID: 30972425
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.
Chen Y; Du J; Zhang Z; Liu T; Shi Y; Ge X; Li YC
Inflamm Bowel Dis; 2014 Nov; 20(11):1910-8. PubMed ID: 25192497
[TBL] [Abstract][Full Text] [Related]
19. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]